Tanning beds could provide a greater risk than originally thought: new study

October 10, 2011 by Deborah Braconnier in Cancer report

(Medical Xpress) -- A new study published in the Journal of Investigative Dermatology has found that, despite previous information, the UVA radiation used in tanning beds may cause more damage to the skin that was originally thought.

Previously it was believed that UVA, which penetrates the deeper layers of the skin, did not play a large role in the aging and wrinkling process, or in , as it did not affect the out layer of skin, or the epidermis.

Co-author Antony R. Young from St. John’s Institute of Dermatology and the team of researchers exposed the buttocks of 12 volunteers to both UVA1 and UVB rays. The UVA1 rays penetrated and caused damage to the basal layer of the skin and induced lesions known as thymine dimers. UVB also caused these lesions in a greater number but they were on the surface of the and not as deep as the UVA1 damage. The doses of UV exposure used in the study were comparable to a sunburn.

The release of this study comes at the same time that the FDA is considering a ban on for children and teens under the age of 18. Governor Jerry Brown from California signed a ban on October 9, 2011 which prohibits the use of tanning beds by minors under the age of 18 in California.

Of course this new information is not making the tanning bed industry happy. John Overstreet, the executive director of the Indoor Tanning Bed Association, points out that tanning beds emit the same ratio of UV waves that the does and that the risk of outdoor sun exposure and tanning bed use is the same. He points out that there is no scientific evidence that shows a non-burning exposure to the sun or tanning beds is linked to the cause of cancer.

This new study does also point out the damaging effects of the sun and the deeper penetrating effects of the UVA rays. It points to the need for labeling changes in broad-spectrum sun products to show that they protect against both UVA and UVB rays.

More information: UVA1 Induces Cyclobutane Pyrimidine Dimers but Not 6-4 Photoproducts in Human Skin In Vivo, Journal of Investigative Dermatology, (6 October 2011) doi:10.1038/jid.2011.283

Abstract
UVB readily induces cyclobutane pyrimidine dimers, mainly thymine dimers (TTs), and pyrimidine (6-4) pyrimidone photoproducts (6-4PPs) in DNA. These lesions result in “UVB signature mutations” found in skin cancers. We have investigated the induction of TTs and 6-4PPs in human skin in vivo by broadband UVA1, and have compared this with comparable erythemal doses of monochromatic UVB (300 nm). In vitro and ex vivo studies have shown the production of TTs, without 6-4PPs, by UVA1. We show that UVA1 induces TTs, without 6-4PPs, in the epidermis of healthy volunteers in vivo, whereas UVB induced both photoproducts. UVB induced more TTs than UVA1 for the same level of erythema. The level of UVA1-induced TTs increased with epidermal depth in contrast to a decrease that was seen with UVB. UVA1- and UVB-induced TTs were repaired in epidermal cells at a similar rate. The mechanism by which UVA1 induces TTs is unknown, but a lack of intra-individual correlation between our subjects’ UVB and UVA1 minimal erythema doses implies that UVA1 and UVB erythema occur by different mechanisms. Our data suggest that UVA1 may be more carcinogenic than has previously been thought.

© 2011 PhysOrg.com

5 /5 (3 votes)  

Rank 5 /5 (3 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

Small cancer risk following CT scans in childhood and adolescence confirmed

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Cancer created 1 hour ago | popularity not rated yet | comments 0

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Novel RNA-based classification system for colorectal cancer

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Low radiation scans help identify cancer in earliest stages

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...

Cancer created 4 hours ago | popularity not rated yet | comments 0

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 6 hours ago | popularity not rated yet | comments 0


New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Life expectancy gap widens between those with mental illness and general population

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...